Showing results (4601-4610 of 5,717) with videos related to

Sort By:
Pageof 572
BMC Nephrology|April 4, 2023
A randomized study to compare oral potassium binders in the treatment of acute hyperkalemiaAlejandro E Cañas, Hayden R Troutt, Luohua Jiang, et al.
BMC Nephrology|March 28, 2021
Fatigue characteristics on dialysis and non-dialysis days in patients with chronic kidney failure on maintenance hemodialysisSubrata Debnath, Rain Rueda, Shweta Bansal, et al.
BMC Nephrology|July 8, 2020
Association of urinary non-albumin protein with the different urinary marker for glomerular and tubular damage in patients with type 2 diabetesKhalid Siddiqui, Salini Scaria Joy, Shaik Sarfaraz Nawaz, et al.
BMC Nephrology|July 8, 2020
Markers of potassium homeostasis in salt losing tubulopathies- associations with hyperaldosteronism and hypomagnesemiaMichael Eder, Elisabeth Darmann, Maria C Haller, et al.
BMC Nephrology|July 31, 2020
Diffuse large B cell lymphoma in a preceding IgG4-related disease with kidney restricted lambda light chain expression: case report and literature reviewHui Wang, Tao Su, Lei Kang, et al.
BMC Nephrology|August 3, 2020
Protocol and establishment of a Queensland renal biopsy registry in AustraliaJoseph Patrick Burke, Manaf Aljishi, Leo Francis, et al.
BMC Nephrology|May 1, 2023
The Minnesota attributable risk of kidney donation (MARKD) study: a retrospective cohort study of long-term (> 50 year) outcomes after kidney donation compared to well-matched healthy controlsDavid M Vock, Erika S Helgeson, Aidan F Mullan, et al.
BMC Nephrology|May 1, 2023
Barriers and facilitators to the transplant process among patients living with polycystic kidney disease: a qualitative ApproachJuliana Smith, Orlando O Harris, Deborah Adey, et al.
BMC Nephrology|May 3, 2023
Cyclic neutropenia and concomitant IgA nephropathy: a case reportC Kapogiannis, T Zaggogianni, N Stergiou, et al.
BMC Nephrology|April 28, 2023
Can regulatory T cells improve outcomes of sensitised patients after HLA-Ab incompatible renal transplantation: study protocol for the Phase IIa GAMECHANgER-1 trialC Dudreuilh, P Jarvis, N Beadle, et al.
Pageof 572